Compare · ALMR vs MTD
ALMR vs MTD
Side-by-side comparison of Alamar Biosciences Inc. (ALMR) and Mettler-Toledo International Inc. (MTD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ALMR and MTD operate in Biotechnology: Laboratory Analytical Instruments (Health Care), so they compete in similar markets.
- MTD is the larger of the two at $34.59B, about 16.2x ALMR ($2.14B).
- MTD has been more active in the news (21 items in the past 4 weeks vs 13 for ALMR).
- MTD has more recent analyst coverage (25 ratings vs 5 for ALMR).
- Company
- Alamar Biosciences Inc.
- Mettler-Toledo International Inc.
- Price
- -
- -
- Market cap
- $2.14B
- $34.59B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Biotechnology: Laboratory Analytical Instruments
- Biotechnology: Laboratory Analytical Instruments
- Exchange
- NASDAQ
- NYSE
- IPO
- 2026
- 1997
- News (4w)
- 13
- 21
- Recent ratings
- 5
- 25
Mettler-Toledo International Inc.
Mettler-Toledo International Inc. manufactures and supplies precision instruments and services worldwide. It operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company offers weighing instruments for laboratory, industrial, packaging, logistics, and food retailing applications; various related analytical instruments and automated chemistry solutions used in drug and chemical compound discovery and development; metal detection and other end-of-line product inspection systems used in production and packaging for food processing and packaging, pharmaceutical, packaged consumer goods, and other industries; and solutions that are used in various process analytics applications. Its laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform. The company's industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, and product inspection systems. Its retail weighing solutions consist of networked scales and software, and stand-alone scales for handling fresh goods, such as meats, vegetables, fruits, and cheeses. The company serves the life science industry, and independent research organizations; food and beverage producers; food retailers; chemical, specialty chemical, and cosmetics companies; food retailers; transportation and logistics, metals, and electronics industries; and the academic community. It markets its products through its direct sales force and indirect distribution channels. The company was incorporated in 1991 and is based in Columbus, Ohio.
Latest ALMR
- Large owner Qiming Corporate Gp Vi, Ltd. sold $2,941,571 worth of shares (100,117 units at $29.38) (SEC Form 4)
- Large owner Qiming Corporate Gp Vi, Ltd. sold $3,327,146 worth of shares (111,313 units at $29.89) (SEC Form 4)
- Alamar Biosciences to Participate in Upcoming Investor Conferences
- SEC Form 10-Q filed by Alamar Biosciences Inc.
- Large owner Qiming Corporate Gp Vi, Ltd. sold $5,676,413 worth of shares (187,636 units at $30.25) (SEC Form 4)
- Alamar Biosciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Financial Statements and Exhibits
- Alamar Biosciences Reports Third Quarter 2026 Financial Results and Raises 2026 Revenue Guidance
- Alamar Biosciences Partners with GSK on Large-Scale Proteomic Study to Advance Precision Medicine
- UPDATE -- Alamar Biosciences and Nightingale Health to Lead UK Biobank 80,000-Sample Neurodegenerative Disease Study
- Alamar Biosciences and Nightingale Health to Lead UK Biobank 80,000-Sample Neurodegenerative Disease Study
Latest MTD
- Director Salice Thomas P was granted 77 shares, increasing direct ownership by 26% to 369 units (SEC Form 4)
- Director Zhang Ingrid was granted 54 shares, increasing direct ownership by 26% to 261 units (SEC Form 4)
- Director Wienand Wolfgang was granted 54 shares, increasing direct ownership by 30% to 237 units (SEC Form 4)
- Director Tokich Michael J was granted 54 shares, increasing direct ownership by 108% to 104 units (SEC Form 4)
- Director Shuman-Fabbri Natalia was granted 54 shares, increasing direct ownership by 338% to 70 units (SEC Form 4)
- Director Shepherd Brian A was granted 54 shares, increasing direct ownership by 37% to 200 units (SEC Form 4)
- Director Perversi Pablo was granted 54 shares, increasing direct ownership by 86% to 117 units (SEC Form 4)
- Director Finney Elisha W was granted 54 shares, increasing direct ownership by 14% to 428 units (SEC Form 4)
- Director Doat-Le Bigot Domitille was granted 54 shares, increasing direct ownership by 18% to 349 units (SEC Form 4)
- Director Diggelmann Roland D was granted 138 shares, increasing direct ownership by 19% to 870 units (SEC Form 4)